144 related articles for article (PubMed ID: 8663303)
21. Down-regulation of DNA topoisomerase IIalpha in human colorectal carcinoma cells resistant to a protoberberine alkaloid, berberrubine.
Kang MR; Chung IK
Mol Pharmacol; 2002 Apr; 61(4):879-84. PubMed ID: 11901227
[TBL] [Abstract][Full Text] [Related]
22. Modulation of DNA topoisomerase II alpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors.
Magan N; Szremska AP; Isaacs RJ; Stowell KM
Biochem J; 2003 Sep; 374(Pt 3):723-9. PubMed ID: 12769819
[TBL] [Abstract][Full Text] [Related]
23. CBF/NF-Y functions both in nucleosomal disruption and transcription activation of the chromatin-assembled topoisomerase IIalpha promoter. Transcription activation by CBF/NF-Y in chromatin is dependent on the promoter structure.
Coustry F; Hu Q; de Crombrugghe B; Maity SN
J Biol Chem; 2001 Nov; 276(44):40621-30. PubMed ID: 11514576
[TBL] [Abstract][Full Text] [Related]
24. Targeting the inverted CCAAT box 2 in the topoisomerase IIalpha promoter by JH-37, an imidazole-pyrrole polyamide hairpin: design, synthesis, molecular biology, and biophysical studies.
Henry JA; Le NM; Nguyen B; Howard CM; Bailey SL; Horick SM; Buchmueller KL; Kotecha M; Hochhauser D; Hartley JA; Wilson WD; Lee M
Biochemistry; 2004 Sep; 43(38):12249-57. PubMed ID: 15379563
[TBL] [Abstract][Full Text] [Related]
25. Identification of conserved cis-elements and transcription factors required for sterol-regulated transcription of stearoyl-CoA desaturase 1 and 2.
Tabor DE; Kim JB; Spiegelman BM; Edwards PA
J Biol Chem; 1999 Jul; 274(29):20603-10. PubMed ID: 10400691
[TBL] [Abstract][Full Text] [Related]
26. p53 modulation of DNA topoisomerase IIalpha gene expression.
Joshi AA; Wang Q; Suttle DP
Cell Biochem Biophys; 2000; 33(2):209-16. PubMed ID: 11325041
[No Abstract] [Full Text] [Related]
27. Molecular cloning and characterization of the promoter for the Chinese hamster DNA topoisomerase II alpha gene.
Ng SW; Eder JP; Schnipper LE; Chan VT
J Biol Chem; 1995 Oct; 270(43):25850-8. PubMed ID: 7592770
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a potential regulatory role for inverted CCAAT boxes in the human topoisomerase II alpha promoter.
Herzog CE; Zwelling LA
Biochem Biophys Res Commun; 1997 Mar; 232(3):608-12. PubMed ID: 9126321
[TBL] [Abstract][Full Text] [Related]
29. Acquisition of multiple copies of a mutant topoisomerase IIalpha allele by chromosome 17 aneuploidy is associated with etoposide resistance in human melanoma cell lines.
Campain JA; Slovak ML; Schoenlein PV; Popescu NC; Gottesman MM; Pastan I
Somat Cell Mol Genet; 1995 Nov; 21(6):451-71. PubMed ID: 8600572
[TBL] [Abstract][Full Text] [Related]
30. Expression of DNA topoisomerases in chronic proliferative kidney disease.
Ivanova LV; Rudolph P; Kellner U; Jürgensen A; Tareeva IE; Alm P; Proppe D
Kidney Int; 2000 Oct; 58(4):1603-12. PubMed ID: 11012894
[TBL] [Abstract][Full Text] [Related]
31. Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization.
Wessel I; Jensen PB; Falck J; Mirski SE; Cole SP; Sehested M
Cancer Res; 1997 Oct; 57(20):4451-4. PubMed ID: 9377550
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of ICBP90, a novel CCAAT-binding protein, overcomes cell contact inhibition by forcing topoisomerase II alpha expression.
Hopfner R; Mousli M; Oudet P; Bronner C
Anticancer Res; 2002; 22(6A):3165-70. PubMed ID: 12530060
[TBL] [Abstract][Full Text] [Related]
33. Hypophosphorylation of topoisomerase IIalpha in etoposide (VP-16)-resistant human carcinoma cell lines associated with carboxy-terminal truncation.
Matsumoto Y; Takano H; Kunishio K; Nagao S; Fojo T
Jpn J Cancer Res; 2001 Jul; 92(7):799-805. PubMed ID: 11473732
[TBL] [Abstract][Full Text] [Related]
34. Structural and functional analysis of the control region of the human DNA topoisomerase II alpha gene in drug-resistant cells.
Takano H; Ise T; Nomoto M; Kato K; Murakami T; Ohmori H; Imamura T; Nagatani G; Okamoto T; Ohta R; Furukawa M; Shibao K; Izumi H; Kuwano M; Kohno K
Anticancer Drug Des; 1999 Apr; 14(2):87-92. PubMed ID: 10405635
[TBL] [Abstract][Full Text] [Related]
35. The cell cycle-coupled expression of topoisomerase IIalpha during S phase is regulated by mRNA stability and is disrupted by heat shock or ionizing radiation.
Goswami PC; Roti Roti JL; Hunt CR
Mol Cell Biol; 1996 Apr; 16(4):1500-8. PubMed ID: 8657123
[TBL] [Abstract][Full Text] [Related]
36. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells.
Kubo T; Kohno K; Ohga T; Taniguchi K; Kawanami K; Wada M; Kuwano M
Cancer Res; 1995 Sep; 55(17):3860-4. PubMed ID: 7641205
[TBL] [Abstract][Full Text] [Related]
37. Stable expression of a dominant negative mutant of CCAAT binding factor/NF-Y in mouse fibroblast cells resulting in retardation of cell growth and inhibition of transcription of various cellular genes.
Hu Q; Maity SN
J Biol Chem; 2000 Feb; 275(6):4435-44. PubMed ID: 10660616
[TBL] [Abstract][Full Text] [Related]
38. Identification of promoter elements responsible for transcriptional inhibition of polo-like kinase 1 and topoisomerase IIalpha genes by p21(WAF1/CIP1/SDI1).
Zhu H; Chang BD; Uchiumi T; Roninson IB
Cell Cycle; 2002 Jan; 1(1):59-66. PubMed ID: 12429910
[TBL] [Abstract][Full Text] [Related]
39. Gene regulation and priming by topoisomerase IIα in embryonic stem cells.
Thakurela S; Garding A; Jung J; Schübeler D; Burger L; Tiwari VK
Nat Commun; 2013; 4():2478. PubMed ID: 24072229
[TBL] [Abstract][Full Text] [Related]
40. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.
Khélifa T; René B; Le Mée S; Lambert B; Saucier JM; Markovits J; Jacquemin-Sablon H; Jacquemin-Sablon A
Cancer Res; 1999 Oct; 59(19):4927-36. PubMed ID: 10519406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]